Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedA new revision entry (v3.6.3) appears in the history on 2026-06-30 with an added Study Status label; the prior revision (v3.6.2) from 2026-05-19 was removed.SummaryDifference0.3%

- Check11 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and an older revision (v3.6.0) was removed from the history, indicating an update to the record's version history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe study history now shows recruitment has ended and the latest revision tag is v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now shows Revision: v3.5.5, indicating an updated version of the page; the previous Revision: v3.5.4 label has been removed.SummaryDifference0.1%

- Check46 days agoChange DetectedNew sections for Contacts/Locations and Study Status were added in the study history, reflecting updated contact details and the current status of the trial. A prior entry dated 2026-04-17 was removed.SummaryDifference0.3%

- Check54 days agoChange DetectedThe page now shows Revision: v3.5.4 instead of v3.5.3, indicating a minor platform update; no study data or visible content appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.